The data to fight cancer is

In this Image.

Look closer...

For 150 years, the way we've diagnosed cancer has been limited to what we can see under a microscope. We are still using the same tools today, but no longer are tools for the eye enough. In the age of information, we need tools for the mind.

Proscia's digital pathology platform is used by thousands of researchers and pathologists to leverage data beyond the glass slide to achieve faster workflows and better outcomes. Our software turns pixels into patterns and insights that will change the way humans look at cancer.

Data Management

Secure cloud infrastructure integrates with all whole slide scanners

Collaboration

Collaborate with pathologists around the world in real time

Image analysis

Extract data from tissue with powerful quantification algorithms

REINVENTING THE FUTURE OF CANCER DIAGNOSIS.

Digital pathology is making it possible to create labs that don't just exist in one place, but everywhere. Connected labs, powered by systems that learn from millions of slides to recognize cancer's patterns faster and more consistently than possible today.

We're building a future of global diagnosis, with harmony between man and machine that turns a universe of information into precision care for every cancer patient.

With the help of partners

We can move forward faster

With best-in-class image analysis applications, Proscia's tissue intelligence technology enables the development of new types of cancer research and diagnostic tools.

If you are committed to advancing pathology and want to make sense of your data, we'd like to talk.

Proscia Releases Commercial Research Edition of its Concentriq Digital Pathology Platform

The new Concentriq Commercial Research Edition is a comprehensive image management solution purpose-built to help life sciences organizations more readily incorporate pathology data into research, discovery, and clinical trials.

Proscia Closes $8.3M Series A Round of Financing

Proscia, the pioneer in the development and advancement of digital pathology, has closed an $8.3 million round of Series A financing from a group of East and West Coast venture capital firms.

Webinar: The Whys and Hows of Adopting Digital Pathology

Join Leica Biosystems and Proscia Digital Pathology as they discuss why institutions are going digital today and how they approach best practices in digital pathology implementation.

Watch the Full Webinar

Proscia, Inc. Named to 2017 Entrepreneur360™ List

Proscia has been named to the 2017 Entreprenuer360™ list by Entrepreneur magazine — a ranking of the top entrepreneurial companies in America.